Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTP1 | P09211 | 1/20 | 0.48 |
| ▸ | DHFR | P00374 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | IKBKB | O14920 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.43 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | AR | P10275 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | GFER | P55789 | 1/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1900896 | 0.90 | ESR1 (0.44) | GSTP1DHFRKDM4EHDAC2IKBKB | |
| SCHEMBL931876 | 0.86 | GSTP1 (0.48) | GSTP1DHFRKDM4EHDAC4HDAC2 | |
| SCHEMBL259164 | 0.85 | GSTP1 (0.47) | GSTP1DHFRKDM4EHDAC4HDAC2 | |
| SCHEMBL35312 | 0.85 | CYP1A2 (0.52) | GSTP1DHFRKDM4EHDAC4HDAC2 | |
| SCHEMBL4450641 | 0.81 | CYP1A1 (0.47) | GSTP1DHFRKDM4EHDAC4HDAC2 | |
| SCHEMBL9319110 | 0.81 | CYP1A2 (0.52) | GSTP1DHFRKDM4EHDAC4HDAC2 | |
| SCHEMBL28127187 | 0.79 | ALDH1A1 (0.47) | GSTP1DHFRKDM4EHDAC4HDAC2 | |
| SCHEMBL24432375 | 0.78 | IKBKB (0.46) | GSTP1DHFRKDM4EIKBKBCYP1A2 | |
| SCHEMBL13643294 | 0.78 | GSTP1 (0.52) | GSTP1DHFRKDM4EHDAC4HDAC2 | |
| SCHEMBL6308539 | 0.78 | GSTP1 (0.52) | GSTP1DHFRKDM4EHDAC4HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9102616-B2 | Organic compound, organic electronic device using same, and terminal for same | DUK SAN NEOLUX CO., LTD. (KR) | 2015-08-11 | — | — | US | disclosed |
| US-20120217492-A1 | ORGANIC COMPOUND, ORGANIC ELECTRONIC DEVICE USING SAME, AND TERMINAL FOR SAME | DUKSAN HIGH METAL CO., LTD. (KR) | 2012-08-30 | — | — | US | disclosed |
| WO-2011055932-A9 | ORGANIC COMPOUND, ORGANIC ELECTRONIC DEVICE USING SAME, AND TERMINAL FOR SAME | 덕산하이메탈(주) (KR) | 2011-09-01 | — | — | WO | disclosed |
| WO-2011055932-A2 | ORGANIC COMPOUND, ORGANIC ELECTRONIC DEVICE USING SAME, AND TERMINAL FOR SAME | 덕산하이메탈(주) (KR) | 2011-05-12 | — | — | WO | disclosed |
| US-5453519-A | Mixing dialkylamines with furfural for stability | EXXON CHEMICAL PATENTS INC. (US) | 1995-09-26 | — | — | US | disclosed |
| US-5332842-A | Phenylene or naphthalene diamine derivatives | EXXON CHEMICAL PATENTS INC. (US) | 1994-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120217492-A1 | ORGANIC COMPOUND, ORGANIC ELECTRONIC DEVICE USING SAME, AND TERMINAL FOR SAME | OR10J3, OR51E2, ORC3 | GSTP1 2004/4885DHFR 2941/4885KDM4E 381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.